EGFR inhibitors
The present disclosure provides a compound represented by structural formula (A) or (I):; or, or a pharmaceutically acceptable salt thereof useful for treating a cancer.
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present disclosure provides a compound represented by structural formula (A) or (I):; or, or a pharmaceutically acceptable salt thereof useful for treating a cancer. |
---|